Maria Contreras
Acute Care · Ypsilanti, MINPI 1285016246
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 62 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $85.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$729
- Corcept Therapeutics$295
- Alnylam Pharmaceuticals Inc.$292
- Amgen$286
- AbbVie$280
- Medtronic$270
- plus $3K from 26 others
What the payments were for
- Food & beverage$5,11196%
- Education$2104%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 7 | $729 |
| Corcept Therapeutics | 3 | $295 |
| Alnylam Pharmaceuticals Inc. | 3 | $292 |
| Amgen | 3 | $286 |
| AbbVie | 3 | $280 |
| Medtronic | 3 | $270 |
| Teva Pharmaceuticals USA, Inc. | 4 | $261 |
| Novo Nordisk | 4 | $237 |
| Johnson & Johnson | 3 | $210 |
| GSK | 2 | $206 |
| Boehringer Ingelheim | 2 | $189 |
| SK Life Science, Inc. | 2 | $175 |
| Molnlycke Health Care US, LLC | 2 | $142 |
| Lundbeck LLC | 1 | $125 |
| Sanofi-aventis U.S. LLC | 1 | $122 |
| Jazz Pharmaceuticals Inc. | 1 | $122 |
| Gilead | 1 | $122 |
| Eisai Inc. | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 1 | $121 |
| Urovant Sciences Inc | 1 | $110 |
| Axsome Therapeutics, Inc. | 1 | $95 |
| Shield Therapeutics Inc | 1 | $93 |
| Janssen Scientific Affairs, LLC | 1 | $93 |
| Neurocrine Biosciences, Inc. | 2 | $89 |
| Amarin Pharma, Inc. | 1 | $89 |
| Merck | 1 | $78 |
| Smith+Nephew | 1 | $70 |
| Pfizer | 2 | $68 |
| Boston Scientific | 1 | $66 |
| CMP Pharma, Inc. | 1 | $63 |
| Acadia Pharmaceuticals Inc | 1 | $62 |
| E.r. Squibb & Sons, L.L.C. | 1 | $41 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,321 in reported general payments places this provider in the 95th percentile of 567 acute care providers in Michigan.
Other acute care in Ypsilanti
- Janet WymanDetroit$103K
- Stephanie Mellon ReppenDetroit$57K
- Ashley WozniakLivonia$26K
- Julia BriggsBirch Run$16K
- Candise LovePort Huron$14K
- Janette GuertinPort Huron$14K
- Gregory AliNovi$13K
- Andrew PalmerLansing$9K
- Angela BrennanDearborn Heights$7K
- Jennifer RutzenLansing$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.